TREATMENT OF HYPERTENSION WITH KETANSERIN, A NEW SELECTIVE 5-HT2 RECEPTOR ANTAGONIST

被引：144
|
作者：
WENTING, GJ
INTVELD, AJM
WOITTIEZ, AJ
BOOMSMA, F
SCHALEKAMP, MADH
机构：
来源：
BRITISH MEDICAL JOURNAL | 1982年 / 284卷 / 6315期
关键词：
D O I：
10.1136/bmj.284.6315.537
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：537 / 539
页数：3
相关论文
共 50 条
  • [41] Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans
    Matthias E Liechti
    Matthias R Saur
    Alex Gamma
    Daniel Hell
    Franz X Vollenweider
    Neuropsychopharmacology, 2000, 23 : 396 - 404
  • [42] Anplag, a selective 5-HT2 receptor antagonist, reduces stenosis induced by balloon injury in the hypercholesterolaemic rabbit
    Origuchi, N
    Shigematsu, H
    Muto, T
    INTERNATIONAL ANGIOLOGY, 1997, 16 (03) : 204 - 209
  • [43] VASCULAR EFFECTS OF KETANSERIN (R-41-468), A NOVEL ANTAGONIST OF 5-HT2 SEROTONERGIC RECEPTORS
    VANNUETEN, JM
    JANSSEN, PAJ
    VANBEEK, J
    XHONNEUX, R
    VERBEUREN, TJ
    VANHOUTTE, PM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1981, 218 (01): : 217 - 230
  • [44] Anplag, a selective 5-HT2 receptor antagonist, reduces stenosis induced by balloon injury in hypercholesterolaemic rabbit
    Jagroop, IA
    Mikhalildis, DP
    INTERNATIONAL ANGIOLOGY, 1998, 17 (01) : 62 - 62
  • [45] PREVENTION BY DV-7028, A SELECTIVE 5-HT2 RECEPTOR ANTAGONIST, OF THE FORMATION OF CORONARY THROMBI IN DOGS
    MORISHIMA, Y
    TANAKA, T
    WATANABE, K
    IGARASHI, T
    YASUOKA, M
    SHIBANO, T
    CARDIOVASCULAR RESEARCH, 1991, 25 (09) : 727 - 730
  • [46] Psychological and physiological effects of MDMA ("ecstasy") after pretreatment with the 5-HT2 antagonist ketanserin in healthy humans
    Liechti, ME
    Saur, MR
    Gamma, A
    Hell, D
    Vollenweider, FX
    NEUROPSYCHOPHARMACOLOGY, 2000, 23 (04) : 396 - 404
  • [47] The role of 5 hydroxytryptamine (5HT) and 5HT2a receptor antagonist ketanserin in placental vascular tone
    Sivasubramaniam, S. D.
    Ugun-Klusek, A.
    Yin, T.
    Loughna, P.
    PLACENTA, 2006, 27 (9-10) : A31 - A31
  • [48] COMPARISON OF BLOOD-PRESSURE RATIO BY DOPPLER VELOCIMETRY AND BY PLETHYSMOGRAPHY DURING TREATMENT WITH KETANSERIN, A 5-HT2 RECEPTOR ANTAGONIST - A MEASURE OF IMPROVED COLLATERAL AND MICROCIRCULATORY FLOW
    DECREE, J
    LEEMPOELS, J
    GEUKENS, H
    VERHAEGEN, H
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 : S92 - S94
  • [49] New therapeutic opportunities for 5-HT2 receptor ligands
    Maroteaux, Luc
    Ayme-Dietrich, Estelle
    Aubertin-Kirch, Gaelle
    Banas, Sophie
    Quentin, Emily
    Lawson, Roland
    Monassier, Laurent
    PHARMACOLOGY & THERAPEUTICS, 2017, 170 : 14 - 36
  • [50] KETANSERIN ANALOGS - STRUCTURE AFFINITY RELATIONSHIPS FOR 5-HT2 AND 5-HT1C SEROTONIN RECEPTOR-BINDING
    HERNDON, JL
    ISMAIEL, A
    INGHER, SP
    TEITLER, M
    GLENNON, RA
    JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (26) : 4903 - 4910
12345